NGeneBio to Raise KRW 6 Billion in Private Placement

• NGeneBio plans to raise KRW 6 billion through a private placement of 6,000,000 common shares at KRW 1,000 each.
• Largest shareholder SH Healthcare Investment No. 1 Partnership will purchase all shares, subject to a one-year lockup.
• Proceeds will fund operating expenses, including personnel costs, in 2027.
• Payment is scheduled for April 1, 2027, with listing set for April 15, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NGeneBio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261110000237), on November 10, 2026, and is solely responsible for the information contained therein.